vs
Side-by-side financial comparison of Prelude Therapeutics Inc (PRLD) and Rithm Property Trust Inc. (RPT). Click either name above to swap in a different company.
Prelude Therapeutics Inc is the larger business by last-quarter revenue ($6.5M vs $3.4M, roughly 1.9× Rithm Property Trust Inc.). Rithm Property Trust Inc. runs the higher net margin — 95.4% vs -303.5%, a 398.8% gap on every dollar of revenue. On growth, Prelude Therapeutics Inc posted the faster year-over-year revenue change (116.7% vs -39.7%).
Rithm Capital Corp. (Rithm) is an American investment management company headquartered in New York that focuses on real estate and alternative investments.
PRLD vs RPT — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.5M | $3.4M |
| Net Profit | $-19.7M | $3.2M |
| Gross Margin | — | — |
| Operating Margin | -314.1% | 99.6% |
| Net Margin | -303.5% | 95.4% |
| Revenue YoY | 116.7% | -39.7% |
| Net Profit YoY | 38.9% | 11.2% |
| EPS (diluted) | $-0.26 | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $3.4M | ||
| Q3 25 | $6.5M | $4.0M | ||
| Q2 25 | — | $4.2M | ||
| Q1 25 | — | $249.0K | ||
| Q3 24 | $3.0M | — | ||
| Q3 23 | — | $1.1M | ||
| Q1 23 | — | $540.0K | ||
| Q4 22 | — | $1.4M |
| Q4 25 | — | $3.2M | ||
| Q3 25 | $-19.7M | $-273.0K | ||
| Q2 25 | — | $1.9M | ||
| Q1 25 | — | $-3.4M | ||
| Q3 24 | $-32.3M | — | ||
| Q3 23 | — | $-5.5M | ||
| Q1 23 | — | $-7.4M | ||
| Q4 22 | — | — |
| Q4 25 | — | 99.6% | ||
| Q3 25 | -314.1% | -6.2% | ||
| Q2 25 | — | 45.7% | ||
| Q1 25 | — | -1416.5% | ||
| Q3 24 | -1145.9% | — | ||
| Q3 23 | — | -533.4% | ||
| Q1 23 | — | -1346.5% | ||
| Q4 22 | — | — |
| Q4 25 | — | 95.4% | ||
| Q3 25 | -303.5% | -6.8% | ||
| Q2 25 | — | 45.1% | ||
| Q1 25 | — | -1363.1% | ||
| Q3 24 | -1075.7% | — | ||
| Q3 23 | — | -526.3% | ||
| Q1 23 | — | -1369.3% | ||
| Q4 22 | — | — |
| Q4 25 | — | $-0.26 | ||
| Q3 25 | $-0.26 | $-0.03 | ||
| Q2 25 | — | $0.01 | ||
| Q1 25 | — | $-0.08 | ||
| Q3 24 | $-0.43 | — | ||
| Q3 23 | — | $-0.25 | ||
| Q1 23 | — | $-0.34 | ||
| Q4 22 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $55.0M | $79.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $58.5M | $291.6M |
| Total Assets | $94.8M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $79.3M | ||
| Q3 25 | $55.0M | $81.4M | ||
| Q2 25 | — | $98.6M | ||
| Q1 25 | — | $97.4M | ||
| Q3 24 | $153.6M | — | ||
| Q3 23 | — | $63.9M | ||
| Q1 23 | — | $49.4M | ||
| Q4 22 | — | $47.8M |
| Q4 25 | — | $291.6M | ||
| Q3 25 | $58.5M | $291.7M | ||
| Q2 25 | — | $294.7M | ||
| Q1 25 | — | $296.1M | ||
| Q3 24 | $156.4M | — | ||
| Q3 23 | — | $320.2M | ||
| Q1 23 | — | $330.4M | ||
| Q4 22 | — | $335.3M |
| Q4 25 | — | $1.0B | ||
| Q3 25 | $94.8M | $1.0B | ||
| Q2 25 | — | $1.0B | ||
| Q1 25 | — | $1.0B | ||
| Q3 24 | $197.2M | — | ||
| Q3 23 | — | $1.4B | ||
| Q1 23 | — | $1.4B | ||
| Q4 22 | — | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-19.1M | $-8.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | -2.56× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-8.3M | ||
| Q3 25 | $-19.1M | $-5.8M | ||
| Q2 25 | — | $-25.0K | ||
| Q1 25 | — | $-1.6M | ||
| Q3 24 | $-27.3M | — | ||
| Q3 23 | — | $-10.7M | ||
| Q1 23 | — | $-16.8M | ||
| Q4 22 | — | $1.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $-27.4M | — | ||
| Q3 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | $1.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | -912.0% | — | ||
| Q3 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | 80.6% |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | 2.1% | — | ||
| Q3 23 | — | 0.0% | ||
| Q1 23 | — | — | ||
| Q4 22 | — | 2.0% |
| Q4 25 | — | -2.56× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.01× | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q3 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
